Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1DEXMEDETOMIDINE[1] Dexmedetomidine[1] Dexmedetomidine 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[14] 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
2Dexmedetomidine 1[1] Dexmedetomidine[1] Dexmedetomidine 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 280 💬
3Dexmedetomidine 2[1] Dexmedetomidine[1] Dexmedetomidine 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 280 💬
4Dexmedetomidine 3[1] Dexmedetomidine[1] Dexmedetomidine 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 280 💬
5Dexmedetomidine group[1] Dexmedetomidine[1] Dexmedetomidine 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 70 💬
6Dexmedetomidine Hcl 100 Mcg/mL Inj[1] Dexmedetomidine[1] Dexmedetomidine 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 215 💬
7DEXMEDETOMIDINE HYDROCHLORIDE[1] Dexmedetomidine[1] Dexmedetomidine 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 70 💬
8Dexmedetomidine Hydrochloride Infusion[1] Dexmedetomidine[1] Dexmedetomidine 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 6 💬
9Dexmedetomidine with ropivacaine[2] Dexmedetomidine,
Ropivacaine
[2] Dexmedetomidine ,
Ropivacaine 💬
[8] ADRA2A,
ADRA2B,
ADRA2C,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
[5] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 💬[1] 70 💬
10Fentanyl (Low Dose) + Dexmedetomidine[2] Dexmedetomidine,
Fentanyl
[2] Fentanyl ,
Dexmedetomidine 💬
[4] ADRA2A,
ADRA2B,
ADRA2C,
OPRM1 💬
[4] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 215 💬
11Scopolamine, atropine, edaravone and dexmedetomidine[4] Atropine,
Dexmedetomidine,
Edaravone,
Scopolamine
[4] Atropine ,
Scopolamine ,
Dexmedetomidine ,
Edaravone 💬
[8] ADRA2A,
ADRA2B,
ADRA2C,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬
[14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 2 💬